Survival in HFpEF vs HFrEF patients after beta-blocker titration: New insights from the CIBIS-ELD trial
16 April 2016 (08:30 - 16:00)
Organised by:
About the speaker

Scirent - Clinical Research and Science, Berlin (Germany)
19 More presentations in this session
Access the full session
The Event
EuroHeartCare 2016
16 April 2016
08:30 CET
